---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-040725"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T08:59:39.547488+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pasithea closes $5M public offering, receives $1.3M from warrant exercises

## Summary
- Offered 3,571,428 units at $1.40/unit (common stock or pre-funded warrant + Series C/D warrants); gross $5M.
- Additional $1.3M from exercise of 914,286 Series D warrants at closing; total gross proceeds $6.3M.
- Net proceeds ~$4.3M after fees and expenses; intended for R&D, clinical trials, and general corporate.
- H.C. Wainwright acted as exclusive placement agent; 7% cash fee plus warrants for 250,000 shares at $1.75.
- 90-day lockup on further equity issuance; one-year restriction on variable rate transactions.

## SEC filing metadata
- accession: 0001213900-25-040725
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025040725/0001213900-25-040725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025040725/ea0241313-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-040725
- JSON: https://secwatch.observer/filing/0001213900-25-040725.json
- Plain text: https://secwatch.observer/filing/0001213900-25-040725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.